Public Release: 

ASHG honors Kári Stefánsson with William Allan Award

Geneticist to receive award at ASHG 2017 annual meeting

American Society of Human Genetics


IMAGE: this is Kári Stefánsson, MD, recipient of ASHG's 2017 William Allan Award (courtesy deCODE Genetics). view more 

Credit: courtesy deCODE Genetics

BETHESDA, MD - The American Society of Human Genetics (ASHG) has named Kári Stefánsson, MD, founder of deCODE Genetics, the 2017 recipient of the annual William Allan Award.

The Allan Award, which recognizes a scientist for substantial and far-reaching scientific contributions to human genetics, was established in 1961 in memory of William Allan, MD (1881-1943), one of the first American physicians to conduct extensive research on human genetics and hereditary diseases. Dr. Stefánsson will receive his award, which will include an engraved medal and $25,000 prize, on Wednesday, October 18, during ASHG's 67th Annual Meeting in Orlando, Florida. He will present his William Allan Award address immediately thereafter.

In 1996, Dr. Stefánsson founded deCODE Genetics with the vision of a large-scale population study in Iceland, a country with a relatively small, isolated, and homogenous population; a high-quality healthcare system; and extensive genealogical records. Through active engagement with the Icelandic population, deCODE has now collected DNA samples from more than 160,000 individuals and contributed greatly to public education about genetics in the country. Their work has inspired similar large-scale studies in other countries, including the UK Biobank and the United States' All of Us initiative.

Central to Dr. Stefánsson's approach is the use of a single unique identifier for each individual, which allows researchers to measure hundreds of different genotypes and phenotypes in the context of each other and has led to important insights. His group published an influential genetic map in 2002, and has identified variants associated with varied phenotypes, such as type 2 diabetes, prostate cancer, heart attack, and schizophrenia. Their research has also helped explain key biological processes, such as recombination, de novo mutations, and parent-of-origin effects.

Dr. Stefánsson has received numerous awards for his work, including the Sackler Lecture at MIT (2009), the European Society of Human Genetics Award (2009), the American Alzheimer's Association's Inge Grundke-Iqbal Award (2014), and the Federation of European Biomedical Societies' Sir Hans Krebs Medal (2016). He has published more than 500 articles in the scientific literature.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.